Cibus, Inc. (NASDAQ:CBUS – Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 2,410,000 shares, an increase of 11.6% from the August 31st total of 2,160,000 shares. Based on an average trading volume of 222,700 shares, the short-interest ratio is currently 10.8 days. Currently, 13.7% of the shares of the company are sold short.
Hedge Funds Weigh In On Cibus
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Armistice Capital LLC purchased a new stake in Cibus in the second quarter worth approximately $5,083,000. Squarepoint Ops LLC bought a new stake in shares of Cibus in the 2nd quarter worth approximately $214,000. Old West Investment Management LLC boosted its stake in shares of Cibus by 3.6% in the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock valued at $524,000 after purchasing an additional 1,868 shares in the last quarter. FineMark National Bank & Trust grew its holdings in shares of Cibus by 24.3% during the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock valued at $202,000 after purchasing an additional 4,000 shares during the last quarter. Finally, Rhumbline Advisers purchased a new position in Cibus in the 2nd quarter worth $221,000. 33.81% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities analysts recently commented on CBUS shares. Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a research note on Friday, July 19th. Canaccord Genuity Group dropped their price objective on shares of Cibus from $21.00 to $20.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. Finally, Alliance Global Partners lowered their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research report on Tuesday, September 24th.
Cibus Trading Up 6.4 %
Shares of CBUS stock traded up $0.21 during trading hours on Tuesday, reaching $3.47. The stock had a trading volume of 113,369 shares, compared to its average volume of 130,988. The stock’s fifty day simple moving average is $6.65 and its 200 day simple moving average is $11.88. The firm has a market capitalization of $74.76 million, a PE ratio of -0.18 and a beta of 1.84. Cibus has a 12 month low of $3.09 and a 12 month high of $23.18.
Cibus (NASDAQ:CBUS – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share for the quarter, missing the consensus estimate of ($0.81) by ($0.33). The firm had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.44 million. Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. During the same period in the previous year, the company posted ($3.05) EPS. As a group, equities research analysts anticipate that Cibus will post -3.84 EPS for the current fiscal year.
About Cibus
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
See Also
- Five stocks we like better than Cibus
- Energy and Oil Stocks Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- 3 Tickers Leading a Meme Stock Revival
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Top 3 Stocks Set to Benefit from China’s Interest Rate Cuts
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.